QF
EPZM

QVT Financial’s Epizyme, Inc EPZM Stock Holding History

QVT Financial’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-355,445
Closed -$6.1M – 84
2017
Q1 		$6.1M Sell
355,445
-174,836
-33% -$2.33M 0.19% 57
2016
Q4 		$6.42M Sell
530,281
-320,165
-38% -$3.34M 0.19% 59
2016
Q3 		$8.37M Sell
850,446
-121,500
-13% -$1.11M 0.32% 48
2016
Q2 		$9.95M Sell
971,946
-209,298
-18% -$2.33M 0.69% 43
2016
Q1 		$14.3M Buy
1,181,244
+585,930
+98% +$5.93M 0.88% 34
2015
Q4 		$9.54M Sell
595,314
-58,514
-9% -$867K 0.54% 46
2015
Q3 		$8.41M Buy
653,828
+43,386
+7% +$876K 0.29% 52
2015
Q2 		$14.7M Sell
610,442
-220,558
-27% -$4.24M 0.22% 45
2015
Q1 		$15.6M Sell
831,000
-112,200
-12% -$2.32M 0.87% 31
2014
Q4 		$17.8M Sell
943,200
-66,400
-7% -$1.55M 0.89% 30
2014
Q3 		$27.4M Hold
1,009,600
– – 1.41% 26
2014
Q2 		$31.4M Buy
1,009,600
+531,900
+111% +$12.5M 1.7% 19
2014
Q1 		$10.9M Buy
477,700
+352,700
+282% +$10.7M 0.62% 50
2013
Q4 		$2.6M Hold
125,000
– – 0.15% 68
2013
Q3 		$5M Hold
125,000
– – 0.34% 56
2013
Q2 		$3.52M Buy
+125,000
New +$3.21M 0.24% 51

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

QVT Financial's EPZM Position: Q2 2017 in Review

QVT Financial sold out of Epizyme, Inc (EPZM) in Q2 2017, closing a stake of 355,445 shares — an estimated $6.1M sold.

QVT Financial first reported a position in EPZM in Q2 2013 and held it in 16 quarters. The position peaked at $31.4M in Q2 2014. 108 funds tracked by Wall St. Rank hold EPZM as of Q2 2017.

  • QVT Financial reported no remaining Epizyme, Inc position as of Q2 2017 after selling out during the quarter.
  • QVT Financial sold 355,445 Epizyme, Inc shares in Q2 2017, an estimated $6.1M.
  • QVT Financial first reported a position in Epizyme, Inc in Q2 2013 and held it in 16 quarters.
  • QVT Financial's Epizyme, Inc position peaked at $31.4M in Q2 2014.
  • 108 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2017.

Based on QVT Financial's 13F filing for Q2 2017, filed 14 Aug 2017.